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We searched for plasmid-mediated quinolone resis-
tance determinants of the Qnr type in several water samples 
collected at diverse locations from the Seine River (Paris, 
France). The qnrS2 genes were identiﬁ  ed from Aeromonas 
punctata subsp. punctata and A. media. The qnrS2 gene 
was located on IncU-type plasmids in both isolates, which 
resulted in increased MIC values of quinolones and ﬂ  uo-
roquinolones, once they were transferred into Escherichia 
coli. The qnrS2 gene identiﬁ  ed in A. punctata was part of 
novel genetic structure corresponding to a mobile insertion 
cassette element. This identiﬁ   cation of plasmid-mediated 
qnr genes outside Enterobacteriaceae underlines a possi-
ble diffusion of those resistance determinants within gram-
negative rods.
Q
uinolones are broad-spectrum antibacterial agents 
used in human and veterinary medicine. Their exten-
sive use has been associated with a rising level of quino-
lone resistance (1). The 2 main mechanisms of quinolone 
resistance are chromosomally encoded, either a modiﬁ  ca-
tion of the quinolone targets with changes of DNA gyrase 
(gyrA) and/or of topoisomerase IV (parC) genes; or a de-
creased intracellular concentration due to impermeability 
of the membrane or to overexpression of efﬂ  ux pump sys-
tems (2). Plasmid-mediated quinolone resistance was ﬁ  rst 
identiﬁ  ed in a Klebsiella pneumoniae clinical isolate from 
the United States (3). It is mediated by a 218-aa protein, 
Qnr (lately termed QnrA), which belongs to the pentapep-
tide repeat family of proteins that protects DNA from qui-
nolone binding to topoisomerases (4,5). QnrA confers re-
sistance to quinolones such as nalidixic acid and increases 
MICs of ﬂ  uoroquinolones up to 32-fold in Escherichia coli 
(6). In addition, it enhances selection of associated chro-
mosome-encoded quinolone resistance determinants that 
confer additional resistance to ﬂ  uoroquinolones (7). The 
QnrA determinants have been reported worldwide in many 
enterobacterial species, and 6 of them are known so far 
(QnrA1 to QnrA6) (8). Other plasmid-mediated quinolone 
resistance determinants, QnrB (QnrB1 to QnrB10) and 
QnrS (QnrS1 and QnrS2), have been identiﬁ  ed in entero-
bacterial species, sharing 41% and 60% amino acid identity 
with QnrA, respectively (8–10). The plasmid-mediated qnr 
genes have been identiﬁ  ed so far only in Enterobacteria-
ceae (6,8). Recent ﬁ  ndings indicated that those genes origi-
nate from environmental gram-negative bacterial species, 
such as Shewanella algae, the progenitor of the qnrA genes 
(11), and Vibrio splendidus, the progenitor of qnrS genes 
(12). We have shown that many Vibrionaceae species may 
harbor chromosome-encoded qnr-type genes (13).
To further evaluate the spread of plasmid-mediated re-
sistance determinants in the environment, we have searched 
for those genes in water samples drawn from the Seine 
River in Paris, France. We identiﬁ  ed QnrS determinants in 
Aeromonas species in uncommon genetic environments.
Materials and Methods
Water Sampling and Screening for qnr Genes
Water samples (40 mL each) were collected in Novem-
ber 2006, ≈0.2 m below the water surface, by immersion of 
50-mL sterile, screw-capped tubes. Six distinct urban sites 
located on the Seine River in Paris were sampled: center 
(site 1), north (site 2), east (site 3), south (site 4), and west 
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(sites 5 and 6). The Seine crosses the city of Paris (2. 4 mil-
lion inhabitants) from southeast to northwest. 
Samples were stored at 4°C before DNA extraction. 
To estimate the total number of viable bacteria, we diluted 
all samples in 0.85% saline solution and plated them (0.2 
mL) on chromogenic URISelect4 agar (Bio-Rad, Marnes-
la-Coquette, France) without any antimicrobial agent, 
which allowed visual differentiation of gram-negative spe-
cies. After enrichment of 1 mL of water sample in 10 mL of 
trypticase soy (TS) broth for 48 h at 30°C and 37°C, qnrA-, 
qnrB- and qnrS genes were detected by using a multiplex 
PCR-based strategy (see below).
Isolation and Identiﬁ  cation of qnr-Positive Isolates
To identify the qnr-positive isolates, 1 mL of each qnr-
positive water sample was grown in 10 mL of TS broth 
containing nalidixic acid (16 mg/L) for 24–48 h at 30°C 
and 37°C. After dilution in 0.85% NaCl, each broth was 
plated (0.2 mL) on chromogenic URISelect4 agar and 5% 
horse-blood TS agar, both containing nalidixic acid (16 
mg/L). Finally, each colony was tested by multiplex PCR 
for detection of qnr genes (see below). Further identiﬁ  ca-
tion of qnr-positive isolates was performed by convention-
al biochemical techniques (API-20E and API-NE systems 
[bioMérieux, Marcy-l’Etoile, France]), and by sequenc-
ing of 16S rDNA and gyrB genes, as previously described 
(14,15).
Isolation of Total DNA and PCR Ampliﬁ  cation
Whole-cell DNA was extracted from water samples 
by using QIAamp DNA Mini Kit (QIAGEN, Courtaboeuf, 
France), according to the manufacturer’s recommenda-
tions. Whole-cell DNA from isolated colonies identiﬁ  ed 
after culture was extracted by using the boiling technique, 
which includes a heating step at 100°C of a single colony 
in a volume of 100 μL of distilled water followed by cen-
trifugation of the cell suspension.
Screening of the qnrA-, qnrB-, and qnrS genes in water 
samples and from isolated colonies was conducted by us-
ing a multiplex PCR-based technique able to amplify the 
known Qnr variants, as previously described (16). E. coli 
Lo, K. pneumoniae B1, and E. coli S7 strains were used 
as qnrA-, qnrB-, and qnrS-positive controls, respectively 
(16,17). PCR amplicons were sequenced on both strands 
(see below). The chromosome-encoded quinolone-resis-
tance determining regions (QRDRs) of gyrA and parC 
genes were sequenced after PCR ampliﬁ  cation by using 
whole-cell DNA of qnr-positive isolates, as previously de-
scribed (18).
PCR assays were also performed by using standard 
conditions of ampliﬁ  cation (17) to detect genes coding for 
the replication protein of IncU-type plasmids (rep gene) 
and the tetracycline resistance determinant (encoded by 
the tetA gene). The primers, designed for this study, are 
as follows: for rep, Rep-IncU-F (5′-CTGGCTGAAAT-
GCTGTTGCC-3′) and Rep-IncU-R (5′-GCTTCATAG-
GCTTCACGCTC-3′) to give a 1,199-bp product, and for 
tetA, TetA-1 (5′-GTGAAACCCAACAGACCCC-3′) and 
TetA-2 (5′-TCAGCGATCGGCTCGTTGC-3′) to give a 
589-bp product.
Antimicrobial Drug–Susceptibility Testing
The antimicrobial drug susceptibility of Aeromonas 
isolates was ﬁ  rst determined by the disk diffusion tech-
nique on Mueller-Hinton (MH) agar plates according to 
Clinical and Laboratory Standards Institute guidelines (19). 
The disks were supplied by Bio-Rad Laboratories, and the 
following antimicrobial agents were tested: amoxicillin 
(25 μg), ticarcillin (75 μg), amoxicillin-clavulanate (20/10 
μg), ticarcillin-clavulanate (75/10 μg), piperacillin (75 μg), 
piperacillin-tazobactam (75/10 μg), cephalothin (30 μg), 
cefuroxime (30 μg), cefoxitin (30 μg), cefotaxime (30 μg), 
ceftazidime (30 μg), aztrem (30 μg), latamoxef (30 μg), 
cefepime (30 μg), imipenem (10 μg), kanamycin (30 IU), 
tobramycin (10 μg), gentamicin (15 μg), netilmicin (30 
μg), amikacin (30 μg), nalidixic acid (10 μg), norﬂ  oxacin 
(5 μg), oﬂ  oxacin (5 μg), ciproﬂ  oxacin (5 μg), chloram-
phenicol (30 μg), tetracycline 30 (IU), fosfomycin (50 μg), 
rifampicin (30 μg), sulfonamide (200 μg), trimethoprim (5 
μg), and colistin (50 μg).
Thus, MICs of quinolones and ﬂ  uoroquinolones were 
determined by using the E test technique, according to the 
manufacturer’s recommendations (AB Biodisk, Solna, 
Sweden). MIC breakpoints were retained for determining 
susceptibility and resistance ranges to nalidixic acid and 
ciproﬂ  oxacin were <8 and >32 mg/L and <1 and >4 mg/
L, respectively, as recommended for Enterobacteriaceae 
(19).
Transfer of Resistance and Plasmid Analysis
Transfer of the plasmid-mediated quinolone resistance 
markers from qnr-positive Aeromonas isolates to E. coli 
TOP10 was attempted by using electroporation and conju-
gation techniques (20). E. coli TOP10 and azide-resistant 
E. coli J53 strains were recipient strains for transformation 
and conjugation experiments, respectively (20). Conjuga-
tion experiments were performed at 22°C and 37°C, as 
previously described (21). Transformants and transconju-
gants were selected on MH agar plates containing nalidixic 
acid (3 mg/L) only or containing azide (100 mg/L) plus 
nalidixic acid (6 mg/L), respectively. Plasmid extraction 
was performed from each qnr-positive isolate and its cor-
responding transformants by using the Kieser technique 
(22). Plasmid sizes were determined by electrophoresis on 
an agarose gel and comparison with sizes of reference plas-
mids (164, 66, 38, and 7 kb) of E. coli NCTC 50192, as pre-
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viously described (20). All transformants were conﬁ  rmed 
to be qnr positive by mulitplex PCR (see above).
Cloning experiments were performed with EcoRI-re-
stricted whole-cell DNA of Aeromonas isolates 37 and 42, 
followed by ligation of DNA fragments in the EcoRI-site 
of cloning vector pBK-CMV. Recombinant plasmids were 
then transformed by electroporation into E. coli TOP10 
electrocompetent cells. E. coli TOP10 harboring recombi-
nant plasmids were selected on MH agar plates contain-
ing kanamycin (30 mg/L) and nalidixic acid (3 mg/L). All 
clones were tested as carrying qnr gene by multiplex PCR 
(see above), and cloned fragments of recombinant plasmids 
were sequenced by primer walking (see below).
Sequencing and Bioinformatic Analysis
PCR products, puriﬁ  ed with a Qiaquick PCR Puriﬁ  -
cation Kit (QIAGEN), and recombinant plasmids were 
sequenced by using an Applied Biosystems sequencer 
(ABI377, Foster City, CA, USA). The nucleotide sequenc-
es and the deduced protein sequences were analyzed with 
BLAST software (www.ncbi.nlm.nih.gov/BLAST).
Results
QnrS2 Determinant from Aeromonas spp.
Samples extracted from 2 of the 6 sites (sites 3 and 4) 
from the Seine River in autumn 2006 were PCR positive 
for qnrS genes. Sequencing of the amplicons identiﬁ  ed a 
qnrS2 gene in both cases. Further samples were therefore 
collected 1 week later from the same collecting sites and 
assessed the permanent occurrence of QnrS2- positive iso-
lates in that river at that time. No qnrA and qnrB genes 
were detected.
The total number of gram-negative bacteria from water 
collection varied from 103 to 105 CFU per mL, depending 
on the sampling site, and included ≈10%–50% of isolates 
belonging to Aeromonas species (data not shown). The 
QnrS2-positive isolates were identiﬁ  ed as Aeromonas spe-
cies according to their phenotypic characterization. Strain 
37 (site 4, pink colonies on URI4Select agar) and strain 42 
(site 3, blue colonies on URI4Select agar) were selected 
as qnrS2-positive Aeromonas isolates to be further charac-
terized. Genotypic identiﬁ  cation was ﬁ  rst attempted by se-
quencing of a ≈1,200-bp fragment of the 16S rDNA gene, 
but sequence analysis did not allow a precise identiﬁ  cation. 
Isolate A37 was identiﬁ  ed as A. trota or A. punctata (for-
merly A. caviae) (only 1 nt difference) and isolate A42 as 
A. hydrophila or A. media (only 1 nt change). Because gyrB 
sequence divergence is greater than that of 16S rDNA, phy-
logenetic analysis based on gyrB sequence (allowing more 
reliable identiﬁ  cation of members of the genus Aeromonas 
[15]) identiﬁ  ed isolate A37 as A. punctata subsp. punctata 
and isolate A39 as A. media.
The Aeromonas isolates both displayed a wild-type re-
sistance phenotype to β-lactams with resistance to narrow-
spectrum penicillins and remained susceptible to several 
β-lactam molecules, including broad-spectrum cephalo-
sporins and carbapenems. A. media 42 was also resistant to 
several aminoglycosides (kanamycin, tobramycin), chlor-
amphenicol, and tetracycline, whereas A. punctata 37 was 
fully susceptible.
Aeromonas isolates 37 and 42 were resistant to nalidix-
ic acid (MIC >256 mg/L) and to ﬂ  uoroquinolones (Table). 
However, A. media 42 exhibited higher resistance levels to 
ﬂ  uoroquinolones, with MICs 2- to 8-fold higher than those 
for A. punctata 37 (Table). Sequence analysis of the QRDR 
regions of gyrA and parC genes showed that A. punctata 37 
had 1 aa substitution, Ser83Ile in GyrA, whereas A. media 
42 had 2 aa substitutions, Ser83Ile in GyrA and Ser80Ile in 
ParC, as compared with the wild-type proteins of Aeromo-
nas species (18).
qnrS2 Gene on IncU-Plasmid Backbone
The plasmid-mediated quinolone resistance QnrS2 de-
terminant was transferred from Aeromonas isolates 37 and 
42 to E. coli TOP10 recipient strain by electrotransforma-
tion, but repeated conjugation experiments failed. Plasmid 
analysis identiﬁ  ed a single 55-kb plasmid (p37) and a sin-
gle 20-kb plasmid (p42) from E. coli transformants from A. 
punctata 37 and A. media 42 isolates, respectively (Figure 
1). After they were transferred into E. coli TOP10, plas-
mids p37 and p42 conferred increased MICs of quinolones 
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Table. MICs (mg/L) of quinolones and fluoroquinolones for Aeromonas punctata 37, A. media 42, and Escherichia coli TOP10 
harboring natural plasmids p37 and p42* 
E. coli TOP10 with plasmids 
Antimicrobial agent  A. punctata 37 A. media 42  p37 p42 E. coli TOP10 
Nalidixic acid  >256 >256 4 4 1
Norfloxacin 16 64 1 1 0.03
Ofloxacin 8 >32 0.5 0.5 0.01
Ciprofloxacin 4 >32 0.12 0.25 <0.01
Moxifloxacin 4 32 0.25 0.25 <0.01
Sparfloxacin 16 >32 0.25 0.25 <0.01
Enrofloxacin 4 >32 0.5 0.5 <0.01
*Each expressing the plasmid-mediated quinolone determinant QnrS2 from A. punctata 37 and A. media 42, respectively, and E. coli reference strain 
TOP10.RESEARCH
and ﬂ  uoroquinolones (Table). No other antimicrobial resis-
tance marker was carried by those natural plasmids.
Cloning of EcoRI-restricted DNA from whole-cell 
DNA of A. punctata 37 produced a recombinant plasmid, 
pAS37, containing a 19,050-bp insert that contained the 
qnrS2 gene. Sequencing showed that the qnrS2 gene was 
located in a plasmid-encoded genetic structure previously 
identiﬁ  ed in an IncU-related plasmid, pFBAOT6 (84,748 
bp), isolated from an A. punctata strain recovered from 
hospital sewage in Kendal (United Kingdom) in 1997 (23). 
This region consisted of 15 open reading frames (Figure 
2). Detailed analysis of pAS37 showed that a fragment of 
1,375 bp containing the qnrS2 gene (657 bp) was inserted 
within the mpR gene coding for a putative zinc metallo-
protease (MpR) (Figure 2). Sequencing of the full insert in 
plasmid pAS37 identiﬁ  ed the same rep region as reported 
from the IncU-related pFBAOT6 plasmid, which indi-
cated that p37 was a member of the IncU incompatibility 
group. PCR ampliﬁ  cation that used speciﬁ  c primers of this 
rep gene also gave positive results from whole-cell DNA 
of E. coli (p42) transformant, indicating that p42 also be-
longed to IncU-type plasmid family. In addition, cloning of 
EcoRI-restricted DNA from whole-cell DNA of A. media 
42 showed that the qnrS2 gene was inserted into the mpR 
gene in plasmid p42. No tetA gene encoding resistance to 
tetracycline was detected by PCR in plasmids p37 and p42, 
whereas it was identiﬁ  ed in plasmid pFBAOT6 (23).
qnrS2 Gene as Part of a Mobile Insertion Cassette
The qnrS2 gene was identiﬁ  ed inside a 1,375-bp struc-
ture bracketed by two 22-bp imperfect inverted repeats (4 
mismatches) (Figure 2). This structure ressembled a trans-
poson; however, no transposase encoding gene was associ-
ated with the qnrS2 gene, the single gene identiﬁ  ed in this 
genetic structure. Acquisition of that structure was likely 
the result of a transposition process because it was brack-
eted by a 5-bp duplication of the target site (CCTCC) that 
might be likely considered as the signature of transposi-
tion. Thus, this genetic structure deﬁ  nes a mobile inser-
tion cassette (mic) containing the qnrS2 gene instead of a 
transposase, as observed in insertion sequences. Those mic 
elements are not related to the gene cassette associated with 
class 1 integrons (26). The mic-qnrS2 element identiﬁ  ed 
here carried putative promoter sequences able to enhance 
the qnrS2 expression made of a –35 box (TTCTCT) and a 
–10 box (TAACTT) separated by a 17-bp sequence.
Discussion
Our study identiﬁ  ed plasmid-mediated quinolone re-
sistance QnrS determinants from water samples collected 
in different sites in a Paris river. To our knowledge, this 
is the ﬁ  rst identiﬁ  cation of plasmid-mediated QnrS deter-
minants in nonenterobacterial species. Previous studies 
did not identify such qnr genes from tested gram-negative 
isolates that represented Campylobacter jejuni (27), Aero-
monadaceae,  Pseudomonadaceae,  Xanthomonadaceae, 
Moraxellaceae, and Shewanellaceae (11). Identiﬁ  cation of 
QnrS-positive isolates at 2 collection sites in different wa-
ter samples may highlight their relative persistence in the 
environment, at least in this area at that time.
The high-level resistance to quinolones and ﬂ  uoroqui-
nolones might be due to mutations in type II topoisomerase 
genes because the mutations described in type II topoisom-
erases in A. media and A. punctata subsp. punctata have 
already been associated with resistance in Aeromonas spp 
(18). QnrS2 may confer low-level resistance to quinolones, 
as known in E. coli.
The qnrS1 gene has been identiﬁ  ed now from sever-
al enterobacterial isolates from Japan (9), Germany (28), 
the United Kingdom (29), the United States (25), France 
(17), Vietnam (30), Taiwan (31,32), and Denmark (33). 
The qnrS2 gene (92% amino acid identity with QnrS1) 
was identiﬁ  ed from a transferable IncQ-related plasmid 
(pGNB2) isolated from an activated sludge bacterial com-
munity of a wastewater treatment plant in Germany (24) 
and in a single non-Typhi Salmonella clinical isolate from 
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Figure 1. Plasmid DNAs from Aeromonas punctata 37 and A. 
media 42 and their Escherichia coli TOP10 transformants (TF) 
carrying plasmids p37 or p42. Lanes: 1, A. punctata 37; 2, E. coli 
TOP10/p37 TF-1; 3, E. coli TOP10/p37 TF-2; 4, A. media 42; 5, E. 
coli TOP10/p42 TF-1; 6, E. coli TOP10/p42 TF-2; M, E. coli NCTC 
50192 (used as reference for plasmid sizes).QnrS Determinants in Aeromonas spp.
the United States (25). Identiﬁ  cation of QnrS determinants 
in Aeromonas spp. indicates that those bacterial species 
may play a role as a reservoir of the qnrS genes in an aquat-
ic environment, as already evidenced for tet genes (34,35). 
However, whether Aeromonas species are a main or an ac-
cessory reservoir of plasmid-mediated quinolone resistance 
determinants in regard to Enterobacteriaceae remains to be 
determined. For Aeromonas spp. to act as a reservoir of qnr 
genes it must be capable of acquiring these resistance genes 
from their progenitors (36) and transferring this genetic in-
formation to Enterobacteriaceae. QnrS2-positive plasmids 
p37 and p42 were not able to be transferred by conjugation 
to an E. coli host in vitro, but they were able to replicate in 
E. coli, indicating their broad host spectrum. In addition, 
our study demonstrated that this IncU-type plasmid-medi-
ated qnrS2 gene was expressed and able to confer reduced 
susceptibility to quinolones, at least in E. coli. Aeromonas 
species and IncU plasmids, which are ubiquitous in a wide 
range of environments, might therefore act as important 
vectors for transfer of plasmid-mediated quinolone resis-
tance determinants (23).
As opposed to most qnrA and qnrB genes, qnrS genes 
have never been reported to be associated with sul1-type 
class 1 integrons (6,8). The qnrS1 gene has been identiﬁ  ed 
either upstream of Tn3-like transposon (9,28) or upstream 
of the insertion sequence ISEcl2 (17,37). In IncQ-related 
plasmid pGNB2 and in pMG308 from a Salmonella isolate, 
surrounding genetic structures of the qnrS2 genes were 
similar, with 2 open reading frames located immediately 
downstream of qnrS2, similar to repC and repA genes in-
volved in plasmid replication (24,25) (Figure 2). In plasmid 
p37 from A. punctata 37, the genetic structure was different 
since the qnrS2 was part of a transposon-like structure and 
inserted in an open reading frame coding for a zinc MpR.
We have shown that plasmid integration of the qnrS2 
gene may result from a peculiar transposition process that 
likely corresponds to trans-transposition. The qnrS2 gene 
was inserted in a peculiar mic. Such mic elements have been 
identiﬁ  ed rarely, e.g., mic231-like elements in Bacillus ce-
reus, carrying in only 1 instance an antibiotic resistance 
gene, the fos gene encoding resistance to fosfomycin (26). 
This ﬁ  nding may indicate that mic elements might be clini-
cally relevant and the origin of an additional gene plasticity 
in a bacterial species. These elements containing genetic 
features involved in gene dissemination (with a transposase 
likely acting in-trans) and expression may be also vehicles 
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 2, February 2008  235 
Figure 2. Genetic environments of the qnrS2 gene in plasmid p37 from Aeromonas punctata 37 and comparison with related plasmid 
structures. Plasmid pFBAOT6 is from A. punctata from the United Kingdom (23); plasmids pGNB2 and pMG308 are from a wastewater 
treatment plant from Germany (unknown bacterial reservoir) (24) and from a non-Typhi Salmonella clinical isolate from the United States 
(25), respectively. Recombinant plasmid pAS37 has been obtained from our study. Open reading frames (ORFs) are indicated by horizontal 
arrows. The right and left inverted repeats (IRR and IRL) are indicated, and duplication sites (CCTCC) are represented by black triangles. 
The EcoRI- restriction sites that have been used for cloning experiments are indicated. The identiﬁ  ed mobile insertion cassette element is 
bracketed by IRL and IRR of 22-bp size (bases in black are identical, and bases in white are different).RESEARCH
for antibiotic resistance genes. This structure type may be 
added to the list of genetic tools at the origin of dissemina-
tion and expression of antibiotic resistance determinants.
As previously described for the spread of a carbapen-
emase gene (blaIMI-2) in US rivers (20), this report under-
lines that the aquatic environment is an important reservoir 
of novel antibiotic resistance determinants. Quinolones are 
antimicrobial agents extensively used in aquaculture and 
are stable molecules in water (as opposed to β-lactams) 
(38). Thus, they may be the source of an important driv-
ing force for selection of quinolone resistance, which ex-
plains why QnrS2-positive plasmids did not possess any 
additional resistance determinants. Further studies might 
focus on the particular effect of quinolone use for inducing 
the qnrS2 gene mobility because it is known those mol-
ecules may induce bacterial repair systems and antibiotic 
resistance gene transfer (39).
We have previously shown that the qnrA and qnrS 
genes originate from water-borne bacterial species, S. al-
gae and Vibrio splendidus, respectively. This identiﬁ  cation 
of a qnrS gene in another water-borne species, Aeromonas, 
further strenghens the role of water as a vehicle for spread 
of those resistance determinants.
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